Showing results (131-140 of 300) with videos related to

Sort By:
Pageof 30
Gynecologic Oncology|April 3, 2025
Consolidation courses in low-risk gestational trophoblastic neoplasia and relapse rate: A MITO-9 retrospective studyRaffaella Cioffi, Robert Fruscio, Giulia Sabetta, et al.
Acta Oncologica (Stockholm, Sweden)|July 4, 2012
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measuresFrancesco Legge, Pasquale A Margariti, Alessandro Lucidi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 15, 2021
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 studyAlice Bergamini, Gabriella Ferrandina, Giorgio Candotti, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 12, 2021
Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow upValerio Gallotta, Soo Young Jeong, Carmine Conte, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2015
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 studyGabriella Ferrandina, Antonietta Gambacorta, Valerio Gallotta, et al.
Cancer Research|November 8, 2014
Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapyLaura Rosanò, Roberta Cianfrocca, Piera Tocci, et al.
Frontiers in Oncology|December 6, 2021
Near-Infrared Imaging With Indocyanine Green for the Treatment of Endometriosis: Results From the Gre-Endo TrialLuigi Carlo Turco, Giuseppe Vizzielli, Virginia Vargiu, et al.
Oncology|November 13, 2004
Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibilityMariagrazia Distefano, Gabriella Ferrandina, Daniela Smaniotto, et al.
Gynecologic Oncology|June 19, 2013
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: a retrospective, multicenter studyGabriella Ferrandina, Vanda Salutari, Bruno Vincenzi, et al.
Gynecologic Oncology|December 21, 2014
Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary?Jessica Ottolina, Gabriella Ferrandina, Angiolo Gadducci, et al.
Pageof 30